Mark Pruzanski Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Mark Pruzanski.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Mark Pruzanski. Mark Pruzanski is President and CEO in INTERCEPT PHARMACEUTICALS INC ($ICPT).
Latest Insider Trading Transactions of Mark Pruzanski
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 03 2013 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President and CEO | Option Exercise | M | 0.00 | 4,867 | 0 | 43,810 | |
| Oct 03 2013 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President and CEO | Buy | M | 0.00 | 4,867 | 0 | 406,899 | 402 K to 406.9 K (+1.21 %) |
| Sep 13 2013 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President and CEO | Option Exercise | M | 9.82 | 7,694 | 75,573 | 33,411 | |
| Sep 13 2013 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President and CEO | Option Exercise | M | 9.82 | 3,906 | 38,366 | 12,500 | |
| Sep 13 2013 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President and CEO | Option Exercise | M | 9.82 | 900 | 8,840 | 16,406 | |
| Sep 13 2013 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President and CEO | Sell | S | 49.05 | 9,804 | 480,886 | 402,032 | 411.8 K to 402 K (-2.38 %) |
| Sep 13 2013 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President and CEO | Sell | S | 48.51 | 1,796 | 87,124 | 411,836 | 413.6 K to 411.8 K (-0.43 %) |
| Sep 13 2013 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President and CEO | Buy | M | 9.82 | 7,694 | 75,573 | 413,632 | 405.9 K to 413.6 K (+1.90 %) |
| Sep 13 2013 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President and CEO | Buy | M | 9.82 | 3,906 | 38,366 | 405,938 | 402 K to 405.9 K (+0.97 %) |
| Sep 13 2013 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President and CEO | Sell | S | 49.65 | 900 | 44,684 | 402,032 | 402.9 K to 402 K (-0.22 %) |
| Sep 13 2013 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President and CEO | Buy | M | 9.82 | 900 | 8,840 | 402,932 | 402 K to 402.9 K (+0.22 %) |
| Aug 13 2013 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President and CEO | Option Exercise | M | 9.82 | 12,500 | 122,779 | 17,306 | |
| Aug 13 2013 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President and CEO | Sell | S | 45.98 | 12,500 | 574,724 | 402,032 | 414.5 K to 402 K (-3.02 %) |
| Aug 13 2013 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President and CEO | Buy | M | 9.82 | 12,500 | 122,779 | 414,532 | 402 K to 414.5 K (+3.11 %) |
| Jul 16 2013 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President and CEO | Option Exercise | M | 9.82 | 21,700 | 213,144 | 29,806 | |
| Jul 16 2013 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President and CEO | Option Exercise | M | 9.82 | 3,300 | 32,414 | 51,506 | |
| Jul 16 2013 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President and CEO | Sell | S | 50.64 | 1,659 | 84,008 | 402,032 | 403.7 K to 402 K (-0.41 %) |
| Jul 16 2013 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President and CEO | Sell | S | 49.78 | 20,041 | 997,675 | 403,691 | 423.7 K to 403.7 K (-4.73 %) |
| Jul 16 2013 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President and CEO | Buy | M | 9.82 | 21,700 | 213,144 | 423,732 | 402 K to 423.7 K (+5.40 %) |
| Jul 16 2013 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President and CEO | Sell | S | 51.83 | 1,300 | 67,374 | 402,032 | 403.3 K to 402 K (-0.32 %) |
| Jul 16 2013 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President and CEO | Sell | S | 51.04 | 2,000 | 102,072 | 403,332 | 405.3 K to 403.3 K (-0.49 %) |
| Jul 16 2013 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President and CEO | Buy | M | 9.82 | 3,300 | 32,414 | 405,332 | 402 K to 405.3 K (+0.82 %) |
| Jul 10 2013 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President and CEO | Option Exercise | M | 9.82 | 10,097 | 99,176 | 54,806 | |
| Jul 10 2013 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President and CEO | Option Exercise | M | 9.82 | 2,403 | 23,603 | 0 | |
| Jul 10 2013 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President and CEO | Option Exercise | M | 9.82 | 25,000 | 245,558 | 2,403 | |
| Jul 10 2013 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President and CEO | Sell | S | 48.26 | 12,500 | 603,259 | 402,032 | 414.5 K to 402 K (-3.02 %) |
| Jul 10 2013 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President and CEO | Buy | M | 9.82 | 10,097 | 99,176 | 414,532 | 404.4 K to 414.5 K (+2.50 %) |
| Jul 10 2013 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President and CEO | Buy | M | 9.82 | 2,403 | 23,603 | 404,435 | 402 K to 404.4 K (+0.60 %) |
| Jul 10 2013 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President and CEO | Sell | S | 45.41 | 25,000 | 1,135,200 | 402,032 | 427 K to 402 K (-5.85 %) |
| Jul 10 2013 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President and CEO | Buy | M | 9.82 | 25,000 | 245,558 | 427,032 | 402 K to 427 K (+6.22 %) |
| Jul 03 2013 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President and CEO | Option Exercise | M | 0.00 | 4,868 | 0 | 48,677 | |
| Jul 03 2013 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President and CEO | Buy | M | 0.00 | 4,868 | 0 | 406,900 | 402 K to 406.9 K (+1.21 %) |
| Jun 27 2013 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President and CEO | Option Exercise | M | 9.82 | 12,300 | 120,814 | 27,403 | |
| Jun 27 2013 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President and CEO | Option Exercise | M | 9.82 | 200 | 1,964 | 39,703 | |
| Jun 27 2013 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President and CEO | Sell | S | 40.06 | 12,300 | 492,745 | 402,032 | 414.3 K to 402 K (-2.97 %) |
| Jun 27 2013 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President and CEO | Buy | M | 9.82 | 12,300 | 120,814 | 414,332 | 402 K to 414.3 K (+3.06 %) |
| Jun 27 2013 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President and CEO | Sell | S | 40.00 | 200 | 8,000 | 402,032 | 402.2 K to 402 K (-0.05 %) |
| Jun 27 2013 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President and CEO | Buy | M | 9.82 | 200 | 1,964 | 402,232 | 402 K to 402.2 K (+0.05 %) |
| Jun 21 2013 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President and CEO | Option Exercise | M | 9.82 | 16,000 | 157,157 | 39,903 | |
| Jun 21 2013 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President and CEO | Option Exercise | M | 9.82 | 9,000 | 88,401 | 55,903 | |
| Jun 21 2013 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President and CEO | Sell | S | 38.35 | 16,000 | 613,597 | 402,032 | 418 K to 402 K (-3.83 %) |
| Jun 21 2013 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President and CEO | Buy | M | 9.82 | 16,000 | 157,157 | 418,032 | 402 K to 418 K (+3.98 %) |
| Jun 21 2013 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President and CEO | Sell | S | 38.08 | 9,000 | 342,751 | 402,032 | 411 K to 402 K (-2.19 %) |
| Jun 21 2013 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President and CEO | Buy | M | 9.82 | 9,000 | 88,401 | 411,032 | 402 K to 411 K (+2.24 %) |
| Apr 11 2013 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President and CEO | Option Exercise | M | 0.00 | 24,339 | 0 | 53,545 | |
| Apr 11 2013 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President and CEO | Payment of Exercise | F | 34.57 | 10,774 | 372,457 | 394,332 | 405.1 K to 394.3 K (-2.66 %) |
| Apr 11 2013 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President and CEO | Buy | M | 0.00 | 24,339 | 0 | 405,106 | 380.8 K to 405.1 K (+6.39 %) |
Page: 1